BEGIN:VCALENDAR
VERSION:2.0
X-WR-CALNAME;VALUE=TEXT:Spring Symposium | 2019
PRODID:-//Harvard events data//EN
BEGIN:VEVENT
UID:event_1514640_0
SUMMARY:Spring Symposium | 2019
DESCRIPTION:<p>	Spring Symposium 2019 focused on lung cancer research specifically. Instead of being viewed as monolithic disease, lung cancers are increasingly recognized as a collection of multiple different disease subtypes, each with its own genetic markers and corresponding therapeutic strategies. Even with targeted treatment, resistance to therapies can arise as a result of an evolutionary process among the mixed population of cancer cells, analogous to how bacterial infections gain resistant to antibiotics. In the advancement of personalized medicine, the treatment of lung cancer stands at the forefront<strong>. </strong></p><p>	Among those in the vanguard leading the way are the symposium’s featured speakers: </p><p>	<strong>Aaron Hata, M.D., Ph.D.</strong><em> </em><br>Evolution of Resistance to Targeted Therapies for Lung Cancer</p><p>	<strong>Tyler Jacks, Ph.D. </strong><br>Engineering the Cancer Genome</p><p>	<strong>Alice T. Shaw, M.D., Ph.D.</strong><em> </em><br>Tumor Evolution and Heterogeneity in Lung Cancer</p><p>	 </p>
LOCATION:NRB
STATUS:CONFIRMED
DTSTART:20190506T160000Z
DTEND:20190506T223000Z
END:VEVENT
END:VCALENDAR